Traditionally, Cx43 was considered as a tumor suppressor in the breast, with many studies reporting decreased Cx43 expression in tumor compared to normal breast tissue via both in vivo and in vitro studies [3,12,13,18,19,20,21]. This evidence concerns the gene GJA1 and neoplasm.